{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:36:56Z","timestamp":1793871416204,"version":"4.6.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050046","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T22:25:15Z","timestamp":1354055115000},"page":"e50046","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":149,"title":["Reduced Glomerular Function and Prevalence of Gout: NHANES 2009\u201310"],"prefix":"10.1371","volume":"7","author":[{"given":"Eswar","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2458-8-117","article-title":"Prevalence of chronic kidney disease in population-based studies: systematic review","volume":"8","author":"QL Zhang","year":"2008","journal-title":"BMC Public Health"},{"key":"ref2","first-page":"161","article-title":"Prevalence of chronic kidney disease and associated risk factors\u2013United States, 1999\u20132004","volume":"56","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"J Coresh","year":"2007","journal-title":"Jama"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, <etal>et al<\/etal>.. (2005) Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 45: A5\u20137, S1\u2013280.","DOI":"10.1053\/j.ajkd.2004.10.009"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"A Enomoto","year":"2002","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-73-3-359","article-title":"Diminished renal urate secretion per nephron as a basis for primary gout","volume":"73","author":"RE Rieselbach","year":"1970","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/ard.39.5.424","article-title":"Gout secondary to chronic renal disease: studies on urate metabolism","volume":"39","author":"LF Sorensen","year":"1980","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0002-9343(67)90246-X","article-title":"The contribution of residual nephrons within the chronically diseased kidney to urate homeostasis in man","volume":"43","author":"TH Steele","year":"1967","journal-title":"Am J Med"},{"key":"ref9","first-page":"633","article-title":"[Secondary Gout in Chronic Nephropathies]","volume":"73","author":"G Richet","year":"1965","journal-title":"Presse Med"},{"key":"ref10","unstructured":"Sarre H (1964) Goutte secondaire a l\u2019insuffisiance renale Travaus de Congres International de la Goutte et de la Lithiase Urique. Paris: Evian. 244\u2013255."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0049-0172(75)90014-1","article-title":"Renal disease in primary gout: a study of 253 gout patients with proteinuria","volume":"4","author":"TF Yu","year":"1975","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Liu Q, Gamble G, Pickering K, Morton S, Dalbeth N (2011) Prevalence and clinical factors associated with gout in patients with diabetes and prediabetes. Rheumatology (Oxford).","DOI":"10.1093\/rheumatology\/ker384"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1136\/ard.2010.130013","article-title":"Impact of diabetes against the future risk of developing gout","volume":"69","author":"G Rodriguez","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","article-title":"Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999","volume":"64","author":"TR Mikuls","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar3272","article-title":"Contemporary epidemiology of gout in the UK general population","volume":"13","author":"L Cea Soriano","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/qjmed\/hcl029","article-title":"Current chronic kidney disease practice patterns in the UK: a national survey","volume":"99","author":"A Ahmad","year":"2006","journal-title":"Qjm"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Liote F, Lancrenon S, Lanz S, Guggenbuhl P, Lambert C, <etal>et al<\/etal>.. (2012) GOSPEL: Prospective survey of gout in France. Part I: Design and patient characteristics (n = 1003). Joint Bone Spine.","DOI":"10.1016\/j.jbspin.2011.12.006"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2369-12-36","article-title":"Chronic kidney disease in gout in a managed care setting","volume":"12","author":"MJ Fuldeore","year":"2011","journal-title":"BMC Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007\u20132008. The American journal of medicine 125: 679\u2013687 e671.","DOI":"10.1016\/j.amjmed.2011.09.033"},{"key":"ref20","unstructured":"(2009\u20132010) Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey."},{"key":"ref21","unstructured":"(2009\u20132010) Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Laboratory Manual. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention."},{"key":"ref22","unstructured":"(2009\u20132010) Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","article-title":"Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study","volume":"157","author":"AC Gelber","year":"1997","journal-title":"Arch Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3899\/jrheum.100418","article-title":"Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts","volume":"38","author":"MA McAdams","year":"2011","journal-title":"J Rheumatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","article-title":"Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?","volume":"118","author":"JF Baker","year":"2005","journal-title":"Am J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Y Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"AV Chobanian","year":"2003","journal-title":"Jama"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"SM Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-157-4-201208210-00003","article-title":"Low-level lead exposure and the prevalence of gout: an observational study","volume":"157","author":"E Krishnan","year":"2012","journal-title":"Annals of internal medicine"},{"key":"ref32","unstructured":"Krishnan E LB, Fries JF, Bhalla V (2010) Lead and gout. going, going, not gone. American College of Rehumatology Annual Scientific Meeting. Atlanta GA."},{"key":"ref33","unstructured":"(2004) Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS): NHANES Laboratory Procedure Manual: Lead Cadmium Mercury."},{"key":"ref34","unstructured":"US Census Bureau: Social E, and Housing Statistics Division (2011) How the Census Bureau Measures Poverty."},{"key":"ref35","unstructured":"(2010) Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS) NHANES -Analytical Guidelines."},{"key":"ref36","unstructured":"Anderson R, Rosenberg H (1998) Age Standardization of Death Rates: Implementation of the Year 2000 Standard In: Statistics NCoH, editor. National vital statistics reports."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"MS Lipkowitz","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"ref38","first-page":"28S","article-title":"Race and kidney disease: role of social and environmental factors","volume":"94","author":"CM Nzerue","year":"2002","journal-title":"J Natl Med Assoc"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","article-title":"Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors","volume":"3","author":"Q Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1525-139X.2007.00270.x","article-title":"Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events","volume":"20","author":"N Dalbeth","year":"2007","journal-title":"Semin Dial"},{"key":"ref41","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout","volume":"33","author":"N Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"YP Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11255-007-9253-3","article-title":"Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions","volume":"39","author":"M Kanbay","year":"2007","journal-title":"Int Urol Nephrol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RHU.0b013e318204aab4","article-title":"Renal function in gout: long-term treatment effects of febuxostat","volume":"17","author":"A Whelton","year":"2011","journal-title":"J Clin Rheumatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T04:52:01Z","timestamp":1562388721000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050046"}},"subtitle":[],"editor":[{"given":"Theodore I.","family":"Steinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050046","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}